Gilead drug produced ’rapid’ recovery in COVID-19 patients, report says

Gilead drug produced ’rapid’ recovery in COVID-19 patients, report says

Gilead Sciences shares surged Thursday following reports detailing encouraging partial data from trials of the U.S. company’s experimental drug remdesivir in COVID-19 patients. A University of Chicago hospital participating in a study on the drug said it is seeing rapid recoveries in fever and respiratory symptoms. Gilead said ’the totality of the data need to be analyzed’.

Kathy
Kathy
Fin
Fin 1 months

One of the best companies In pharma with some of greatest minds for producing quality anti protease inhibitors n other pharmakinectics.. Thank u

😈😈😈😈😈
😈😈😈😈😈 1 months

Gilead? As in The Handmaid’s Tale?

Top in Business
Get the App